Vincent Mark D. 4
4 · Aptose Biosciences Inc. · Filed Jan 6, 2021
Insider Transaction Report
Form 4
Vincent Mark D.
Other
Transactions
- Award
Director Stock Option (Right to Buy)
[F1][F2]2021-01-04+50,000→ 50,000 totalExercise: $4.38Exp: 2031-01-04→ Common Shares (50,000 underlying)
Footnotes (2)
- [F1]Converted from Canadian exercise price of C$5.58 using an exchange rate of C$1.2751 = US$1.00.
- [F2]The options were granted on January 4, 2021, and vest as follows: 50% vest on January 4, 2022; 25% vest on January 4, 2023; and 25% vest on January 4, 2024.
Signature
/s/ Janet Clennett as attorney-in-fact for Mark D. Vincent|2021-01-06